Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Valacyclovir × 30 days × Clear all

Phase

Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 51 Carboplatin 37 Specimen Handling 33 Magnetic Resonance Spectroscopy 30 Biopsy 30 Cyclophosphamide 29 Nivolumab 24 Dexamethasone 22 fludarabine 21 Paclitaxel 19 Gemcitabine 19 Bevacizumab 19 venetoclax 17 Pemetrexed 17 Rituximab 14 Cisplatin 14 Temozolomide 13 Lenalidomide 13 atezolizumab 12 Prednisone 12 Cetuximab 12 Azacitidine 12 Fulvestrant 10 Vincristine 9 Irinotecan 9 fludarabine phosphate 8 durvalumab 8 carfilzomib 8 aldesleukin 8 X-Rays 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346144 2026-03-04

ADePT

Trogenix ltd

Phase 1/2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡